Topiramate

Migraine, Caloric Restriction, High cholesterol + 16 more

Treatment

20 Active Studies for Topiramate

What is Topiramate

Topiramate

The Generic name of this drug

Treatment Summary

Topiramate is a medication used to control seizures and prevent migraine headaches. It was first approved by the FDA in 1996 and later approved for migraine prevention in adults in 2004. Topiramate is also used in combination with phentermine to help adults manage their weight. It contains a monosaccharide chemical structure with sulfamate and 40% of its mass is oxygen. Topiramate was originally developed as an antidiabetic drug, but was found to be an effective antiepileptic drug by chance.

Topamax

is the brand name

image of different drug pills on a surface

Topiramate Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Topamax

Topiramate

1997

526

Effectiveness

How Topiramate Affects Patients

Topiramate helps to stop seizures and migraine symptoms by calming down the nerve pathways in the brain. However, it can also cause health problems like acid in the blood, changes in mood, suicidal thoughts, and kidney stones. Taking topiramate together with another drug called valproic acid may also cause a low body temperature.

How Topiramate works in the body

Seizures are caused by an uncontrolled electrical discharge in the brain. Topiramate helps to control seizures and migraines by increasing the activity of GABA-A receptors, which are usually inhibitory, and decreasing glutamate activity, which is usually stimulating. It also blocks voltage-dependent sodium channels, preventing seizures from occurring. Lastly, it has been seen to inhibit carbonic anhydrase isozymes, though the impact of this is not yet known.

When to interrupt dosage

The proposed dosage of Topiramate is contingent upon the diagnosed state, for example Seizures, Weight Reduction and Tonic - clonic seizures. The measure can be found in the accompanying table, based on the mode of administration (e.g. Tablet, coated or Tablet).

Condition

Dosage

Administration

Alcoholism

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Obesity

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Exercise

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Lennox Gastaut Syndrome

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Migraine

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Caloric Restriction

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

High cholesterol

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Obesity

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

at least one weight-related comorbid condition

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Migraine Disorders

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Obesity

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Seizures

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Type 2 Diabetes

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Hypertensive disease

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Epilepsy

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Weight Loss

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

increase in physical activity

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Mood Disorders

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Chronic Weight Management therapy

, 25.0 mg, 100.0 mg, 200.0 mg, 50.0 mg, 150.0 mg, 15.0 mg, 23.0 mg, 46.0 mg, 69.0 mg, 92.0 mg, 25.0 meq, 25.0 mg/mL

, Tablet, Oral, Tablet - Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, coated - Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, coated, Capsule, coated pellets - Oral, Capsule, coated pellets, Capsule - Oral, Capsule, Solution, Solution - Oral

Warnings

Topiramate Contraindications

Condition

Risk Level

Notes

Acidosis

Do Not Combine

There are 20 known major drug interactions with Topiramate.

Common Topiramate Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be increased when combined with Topiramate.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be increased when combined with Topiramate.

Acenocoumarol

Major

The metabolism of Acenocoumarol can be increased when combined with Topiramate.

Alectinib

Major

The metabolism of Alectinib can be increased when combined with Topiramate.

Alpelisib

Major

The metabolism of Alpelisib can be increased when combined with Topiramate.

Topiramate Toxicity & Overdose Risk

The lowest toxic dose of topiramate in rats is greater than 1500mg/kg. In a study of 4 women taking topiramate, symptoms of overdose ranged from mild to severe, but no deaths were reported. Symptoms of overdose may include low blood pressure, extreme acidity in the body, coma, abdominal pain, vision problems, seizures, drowsiness, difficulty speaking or thinking, confusion or agitation, dizziness, and depression. If the overdose was recent, the stomach contents can be emptied using vomiting or a stomach pump. Treatment may also include activated charcoal and dialysis.

image of a doctor in a lab doing drug, clinical research

Topiramate Novel Uses: Which Conditions Have a Clinical Trial Featuring Topiramate?

313 clinical trials are currently underway to assess the potential of Topiramate to treat Type 2 Diabetes, Migraine and Exercise-related conditions.

Condition

Clinical Trials

Trial Phases

Exercise

57 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Weight Loss

0 Actively Recruiting

Mood Disorders

0 Actively Recruiting

Migraine

51 Actively Recruiting

Phase 4, Not Applicable, Phase 1, Phase 3, Phase 2, Early Phase 1

Obesity

0 Actively Recruiting

Chronic Weight Management therapy

0 Actively Recruiting

Migraine Disorders

1 Actively Recruiting

Phase 3

Hypertensive disease

27 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3

Seizures

5 Actively Recruiting

Phase 3, Phase 2, Phase 1

High cholesterol

0 Actively Recruiting

Obesity

0 Actively Recruiting

at least one weight-related comorbid condition

0 Actively Recruiting

Lennox Gastaut Syndrome

2 Actively Recruiting

Phase 1, Phase 2, Phase 4

Obesity

0 Actively Recruiting

Caloric Restriction

0 Actively Recruiting

Epilepsy

0 Actively Recruiting

Alcoholism

7 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Type 2 Diabetes

162 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4, Early Phase 1

increase in physical activity

0 Actively Recruiting

Topiramate Reviews: What are patients saying about Topiramate?

4.3

Patient Review

3/20/2022

Topiramate for Migraine Prevention

I've been taking Topamax for over 15 years and it's really helped me. I know some people can't take the drug, but for me it's been a life-saver. The only downside is that now I have to take the generic form (because of my insurance) and it doesn't work nearly as well.

4

Patient Review

2/21/2022

Topiramate for Migraine Prevention

I've been on topimax for 11 years. The only side effect I've experienced is weight loss, which pleases me.

3.7

Patient Review

3/25/2022

Topiramate for Migraine Prevention

I've been taking Topiramate for migraines and have experienced some very negative side effects, including depression, anxiety, and diarrhea. I would not recommend this medication to others.

2

Patient Review

3/6/2022

Topiramate for Migraine Prevention

After taking the second 25mg dose of Topiramate, I started feeling numb in my face and arms when I woke up. My depression was really bad. After 4 days, I developed closed-angle glaucoma and could have lost my vision permanently if I hadn't gotten help right away.

1.7

Patient Review

3/31/2022

Topiramate for Migraine Prevention

I would not recommend this medication to anyone. While it did help with my migraines, the side effects were really severe. I had tingling in my extremities and slurred speech--to the point where my colleagues thought I'd actually had a stroke. Do not take this drug.

1

Patient Review

4/29/2022

Topiramate for Tonic-Clonic Epilepsy

I've been on 25 mg of this medication for one month now, and it has really messed with my taste buds, sleep patterns, and mouth. I constantly have headaches (which the doctor says are not migraines) and feel like bugs are crawling all over me. She is slowly weaning me off of the medication, but it has been a nightmare.

1

Patient Review

5/2/2022

Topiramate for Migraine Prevention

After taking just two doses of this medication, I started feeling tingling and numbness. Additionally, I felt scared and my brain fogged up. Plus, my eyes started feeling weird too. Needless to say, I won't be taking anymore of this drug; it's straight in the trash.

1

Patient Review

5/9/2022

Topiramate for Migraine Prevention

I am a 54 year old healthy female who started taking topiramate 25 mg 2 weeks ago for chronic migraines. I have felt horrible since then. My eyes feel heavy, I have a weird head feeling, and I'm more depressed than ever. I also feel like I have a head cold and my thinking is not clear. I am going no further with this medicine because it has caused me a lot of pain both mentally and physically.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about topiramate

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the serious side effects of topiramate?

"If you experience any of the following side effects, it could be a sign of a more serious condition and you should seek medical attention immediately: pain in your back, belly or side; a burning sensation when you pee; cloudy or smelly pee; feeling sleepy; losing your appetite; or having an irregular heartbeat."

Answered by AI

What is the drug topiramate used for?

"UK Topiramate is a medicine to treat epilepsy and migraine."

Answered by AI

What is the most common side effect of topiramate?

"You may experience fatigue, drowsiness, dizziness, loss of coordination, tingling in your extremities, decreased appetite, bad taste in your mouth, diarrhea, and weight loss."

Answered by AI

What does Topamax do to your body?

"Topiramate is a type of medication used to treat seizures. It works by decreasing the abnormal excitement in the brain."

Answered by AI

Clinical Trials for Topiramate

Image of Faculty of Health Sciences in Winnipeg, Canada.

Saskatoon Berries for Type 2 Diabetes

18 - 74
All Sexes
Winnipeg, Canada

Diabetes becomes epidemic in worldwide countries. Diabetes Canada indicated that 30% of adults in Manitoba are diabetes or prediabetes. Nine out of ten diabetic patients are type 2 diabetes (T2D). T2D is characterized by insulin resistance and obesity. Uncontrolled diabetes leads to serious consequences including heart attack, stroke, chronic renal failure, liver failure, blindness and low limb amputation. Most of hypoglycemic medications have certain side effects. Natural foods or nutraceuticals with hypoglycemic potential are expected to provide a safer management for diabetic patients. Saskatoon berry is a popular fruit in Canadian Prairie and Northern states in USA. Our previous studies demonstrated Saskatoon berry (SB) powder attenuated hyperglycemia, hyperlipidemia, insulin resistance, inflammation, liver steatosis and gut dysbiosis in diet-induced insulin resistant mice, a model for T2D. The findings of the glucose and lipid lowering or liver protective effects of SB powder have been supported by another group in Australia in high fat fed rats. Our preliminary studies in 20 healthy subjects demonstrated that dried whole SB (40 g/day for 10 weeks) significantly reduced fasting plasma glucose, total and LDL-cholesterol, systolic blood pressure, and increased plasma glucagon-like peptide compared to baseline, which was associated with increased intake of total fiber and decreased intake of saturated fat. The changes in metabolic and vascular variables significantly correlated with the alterations in gut microbiota The combination of findings suggest that SB is good candidate of prebiotic functional food as a supplemental remedy for reducing the risk for metabolic syndrome and preventing or managing T2D. The effect of Saskatoon berry and its products on metabolic disorders have not been studied in diabetic subjects. We propose to examine the effects of oral administration of freeze-dried whole SB on glucose metabolism, insulin resistance and gut microbiota in untreated prediabetes and new type 2 diabetic patients compared to a control dried fruit in a randomized controlled trial.

Waitlist Available
New This Month

Faculty of Health Sciences

Image of Arkansas Children's Research Institute in Little Rock, United States.

We Move with Windy for Motor Skills

Any Age
All Sexes
Little Rock, AR

The long-term goal of this project is to learn whether a tailored physical activity program is practical, enjoyable, and helpful for families, and whether it has the potential to improve children's physical development and health. Before launching a large study, the research team completed several early phases to make sure the program met families' needs. First, a needs assessment was conducted with mothers to understand barriers to physical activity and what types of support would be most useful. Using this feedback, the program was refined and tested with three mother-child pairs over six weeks. Finally, there was an 18-week pilot randomized trial to examine feasibility and acceptability. Researchers are now conducting a larger randomized trial with up to 266 families. Half of the families are randomly assigned to receive the physical activity program, and half to a comparison group. The program combines fun, age-appropriate movement activities for children with practical support for parents. Sessions focus on building core movement skills such as jumping, balancing, running, and throwing, while also encouraging confidence, coordination, and enjoyment of being active. Activities can be adapted to each child's ability and home environment, making the program realistic for busy families. The program includes both in-person sessions and technology-based activities. In-person sessions provide hands-on support for learning new skills. Technology-based activities offer simple ideas families can use at home or during daily routines, such as hopping games, balance challenges, or quick movement breaks. Because parents in earlier phases wanted nutrition support, in-person sessions also includes a brief, child-friendly exposure to fruits and vegetables, along with simple recipes. A "Tasting Party" at the start of the program allows children to try different foods, and Veggie Meter scans at the beginning and end of the study help track changes in fruit and vegetable intake. Overall, this study will help determine whether a family-tailored physical activity program is a promising approach to improving physical activity, movement skills, and early health indicators in young children born to mothers with obesity.

Recruiting
Has No Placebo

Arkansas Children's Research Institute

Taren Swindle

Image of Arkansas Children's Research Institute in Little Rock, United States.

Exercise Program for Pregnant Women

18+
Female
Little Rock, AR

Regular physical activity during pregnancy is safe and offers many health benefits for both mothers and their babies. Research over the past decade shows that exercise can help pregnant women gain a healthy amount of weight, lower their risk of gestational diabetes and high blood pressure, and reduce stress, anxiety, and symptoms of postpartum depression. Babies also benefit when their mothers are active, with lower risks of preterm birth, unhealthy birth size, and childhood obesity. Despite this strong evidence, very few exercise programs for pregnant women have been tested in real-world community settings, such as fitness centers, community health programs, or local organizations. Even fewer studies explain how these programs were delivered or what helped them succeed. Without this information, it is difficult for communities and health programs to offer exercise support that is both effective and practical for pregnant women. To address this gap, the research team adapted an evidence-based program called EXPECTING so it could be delivered by community organizations. Previous participants and community advisors helped to understand what changes were needed to make the program easier to offer while still keeping it safe and effective. The core parts of the program, including the type, amount, and intensity of aerobic and strength-building exercises, remained the same and are based on established pregnancy exercise guidelines. The adapted program, called COMMUNITY EXPECTING, includes both aerobic exercise and resistance training. The research team also developed specific supports to help community instructors deliver the program consistently and with confidence. All program components have already been tested in community settings and shown to be realistic, acceptable, and delivered as planned. This study will examine whether offering a structured exercise program in community settings helps pregnant women be more physically active than usual prenatal care alone. We will also assess whether the program can be delivered successfully and in a way that works for both participants and community providers. The results will help determine whether COMMUNITY EXPECTING is a practical approach for supporting healthy pregnancies in real-world settings.

Recruiting
Has No Placebo

Arkansas Children's Research Institute

Taren Swindle

Have you considered Topiramate clinical trials?

We made a collection of clinical trials featuring Topiramate, we think they might fit your search criteria.
Go to Trials
Image of Miles Square Health Center Chicago in Chicago, United States.

Food is Medicine for High Blood Pressure and Obesity

Any Age
All Sexes
Chicago, IL

The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?

Phase 2
Waitlist Available

Miles Square Health Center Chicago (+3 Sites)

Have you considered Topiramate clinical trials?

We made a collection of clinical trials featuring Topiramate, we think they might fit your search criteria.
Go to Trials
Image of Arizona State University in Phoenix, United States.

App-based Breathing Program for Migraine

18+
All Sexes
Phoenix, AZ

Migraine is one of the most common neurological disorders, characterized by recurrent headaches, sensitivity to light and movement, nausea, and autonomic dysregulation. Although mind-body interventions like biofeedback have shown their efficacy, they remain underutilized due to barriers such as transportation, time constraints, lack of awareness, stigma, and cost. A targeted approach to enhancing HRV is HRV biofeedback (HRVB), a technique using visual or auditory feedback to help people regulate HRV through slow-paced breathing and positive emotional regulation to promote ANS balance and emotional resilience. Investigators will conduct a remotely delivered pilot RCT of an 8-week, 10 min/day, novel app-based HRVB intervention compared to a sham control intervention (matching intervention time and attention with no biofeedback component) in adult with chronic migraine. Investigators hypothesize data collected from the study will: a) support the feasibility and acceptability of the remotely delivered app-based HRVB intervention among adults with chronic migraine, and b) provide insights into refining the intervention by examining patterns of change in migraine and psychological outcomes from pre- to post-intervention.

Waitlist Available
Online Trial

Arizona State University

Image of Human Performance Clinical Research Lab in Fort Collins, United States.

Virtual Exercise for Cancer

18+
All Sexes
Fort Collins, CO

The goal of this research study is to look at how live, online group exercise compares to recorded videos for helping increase physical activity levels, improve physical fitness and quality of life, and reduce loneliness among those living with and beyond cancer. The following aims have been established for this study: * Aim 1: Examine the effect of a group-based videoconference physical activity (PA) intervention on moderate to vigorous physical activity \[MVPA\] (i.e., aerobic and resistance exercise). * Aim 2: Examine the effect of the intervention on additional health-related outcomes including physical fitness (i.e., aerobic endurance, muscular strength), and quality of life at both timepoints. * Aim 3: Explore potential mediators and moderators of intervention effects. We will examine mediators (e.g., self-efficacy, outcome expectations, group cohesion) and moderators (e.g., age, cancer stage, neighborhood walkability) of the intervention on MVPA. * Exploratory Aim: Determine whether a group-based videoconference PA intervention reduces loneliness among cancer survivors. Researchers will randomize participants into one of two guided exercise groups that are 12-weeks long in duration. Participants will be asked to complete online fitness assessments and surveys as well as wear a physical activity monitor device and watch a few times throughout the study. The whole study is 9-months long in duration with a 6-month free-living period where no study activities will take place.

Recruiting
Has No Placebo

Human Performance Clinical Research Lab

Heather J Leach, PhD

Image of NYU Langone Health in New York, United States.

Adaptive Dietary Intervention for Type 2 Diabetes

18+
All Sexes
New York, NY

The investigators will examine the feasibility, acceptability, and effect of an adaptive dietary intervention over 24 weeks (12-week intervention, 12-week follow-up) among Asian Americans with Type 2 diabetes. Participants (N=120; 60 Chinese Americans and 60 Vietnamese Americans) will be 2:1 randomized to one of two arms: adaptive dietary intervention or standard of care (SC). The intervention will begin with continued glucose monitoring (CGM) use only during weeks 0-4. At week 4, participants who achieve the glycemic control goal (at least an 8% increase in time in range \[TIR\] from baseline) will continue with the CGM alone during weeks 4-12 ("CGM Alone"); otherwise, culturally and linguistically adapted glucose excursion minimization (GEM) will be augmented with CGM ("CGM-GEM").

Waitlist Available
Has No Placebo

NYU Langone Health

Yaguang Zheng, PhD, RN

Have you considered Topiramate clinical trials?

We made a collection of clinical trials featuring Topiramate, we think they might fit your search criteria.
Go to Trials